Long-term consequences of COVID-19
perspectivas12_llamosas
Keywords:
COVID-19, Long-term consequencesAbstract
At this stage of the pandemic, there are studies that have analyzed the long-term consequences secondary to COVID-19 infection. Studying these sequelae is essential to understand the natural history of the disease, predict the impact it has beyond hospitalization and mortality, and determine whether post-discharge rehabilitation should be considered.
The consequences and complications were observed in the previous coronavirus epidemics that caused Severe Acute Respiratory Syndrome (SARS) in 2002 and Middle East Respiratory Syndrome (MERS) from 2012 to the present day. Reduced lung function and exercise capacity, post-traumatic stress disorder, depression, anxiety and reduced quality of life were observed in some affected people, suggesting that it is likely that SARS-CoV-2 may have a similar impact.
During the pathophysiological process, an intense inflammatory response is generated, first affecting the respiratory tract and subsequently the cardiovascular, central and peripheral nervous system, and skeletal muscle, in addition to the psychiatric and psychological effects that it can trigger.
Downloads
References
Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M et al. Long-term consequences of COVID-19: research needs. Lancet Infect Dis [Internet]. octubre de 2020;20(10):1115-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32888409
Ahmed H, Patel K, Greenwood DC, Halpin S, Lewthwaite P, Salawu A et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med [Internet]. mayo de 2020;52(5):jrm00063. Disponible en: http://europepmc.org/abstract/MED/32449782
Dasgupta A, Kalhan A, Kalra S. Long term complications and rehabilitation of COVID-19 patients. JPMA The Journal of the Pakistan Medical Association [Internet]. mayo de 2020;70(Suppl 3)(5):S131-5. Disponible en: http://europepmc.org/abstract/MED/32515393
Ojo AS, Balogun SA, Williams OT, Ojo OS. Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies. Kuwano K, editor. Pulmonary Medicine [Internet]. 11 de agosto de 2020;2020:6175964. Disponible en: https://doi.org/10.1155/2020/6175964
Vasarmidi E, Tsitoura E, Spandidos DA, Tzanakis N, Antoniou KM. Pulmonary fibrosis in the aftermath of the Covid-19 era (Review). Exp Ther Med [Internet]. 1 de septiembre de 2020;20(3):2557-60. Disponible en:
https://doi.org/10.3892/etm.2020.8980
Wei J, Yang H, Lei P, Fan B, Qiu Y, Zeng B et al. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge. J Xray Sci Technol [Internet]. 2020;28(3):383-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32474479
Yu M, Liu Y, Xu D, Zhang R, Lan L, Xu H. Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia. Korean J Radiol. junio de 2020;21(6):746-55.
Mo X, Jian W, Su Z, Chen M, Peng H, Peng P et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J [Internet]. 18 de junio de 2020;55(6):2001217. Disponible en:
https://pubmed.ncbi.nlm.nih.gov/32381497
Carfì A, Bernabei R, Landi F. For the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA [Internet]. 11 de agosto de 2020 [citado 19 de octubre de 2020];324(6):603-5. Disponible en:
https://doi.org/10.1001/jama.2020.12603
Fiani B, Covarrubias C, Desai A, Sekhon M, Jarrah R. A Contemporary Review of Neurological Sequelae of COVID-19. Front Neurol [Internet]. 23 de junio de 2020;11:640-640. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32655489
Kosugi EM, Lavinsky J, Romano FR, Fornazieri MA, Luz-Matsumoto GR, Lessa MM et al. Incomplete and late recovery of sudden olfactory dysfunction in COVID-19,. Brazilian Journal of Otorhinolaryngology. 2020;86:490-6.
Li J, Long X, Zhu C, Wang H, Wang T, Lin Z et al. Olfactory Dysfunction in Recovered Coronavirus Disease 2019 (COVID-19) Patients. Mov Disord [Internet]. julio de 2020;35(7):1100-1. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32468632
Otte M, Klussmann J, Luers J. Persisting olfactory dysfunction in patients after recovering from COVID-19. The Journal of infection [Internet]. septiembre de 2020;81(3):e58. Disponible en: http://europepmc.org/abstract/MED/32592702
Lu Y, Li X, Geng D, Mei N, Wu PY, Huang CC et al. Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study. EClinicalMedicine [Internet]. 3 de agosto de 2020;25:100484-100484. Disponible en: https://www.unboundmedicine.com/medline/citation/32838240/Cerebral_Micro-Structural_Changes_in_COVID-19_Patients_-_An_MRI-based_3-month_Follow-up_Study
Mitrani RD, Dabas N, Goldberger JJ. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm [Internet]. 26 de junio de 2020;S1547-5271(20)30625-1. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32599178
Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clinical Microbiology and Infection [Internet]. 23 de septiembre de 2020; Disponible en: http://www.sciencedirect.com/science/article/pii/S1198743X20305759
Sardari A, Tabarsi P, Borhany H, Mohiaddin R, Houshmand G. Myocarditis detected after COVID-19 recovery. European heart journal cardiovascular Imaging [Internet]. mayo de 2020; Disponible en: http://europepmc.org/abstract/MED/32462177
Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiology [Internet]. 27 de julio de 2020 [citado 19 de octubre de 2020]; Disponible en: https://doi.org/10.1001/jamacardio.2020.3557
Szcześniak D, Gładka A, Misiak B, Cyran A, Rymaszewska J. The SARS-CoV-2 and mental health: From biological mechanisms to social consequences. Prog Neuropsychopharmacol Biol Psychiatry [Internet]. 10 de enero de 2021;104:110046-110046. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32730915
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Laura Stephanie Llamosas Falcón
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
